title: [Contrast substances-induced nephropathy].
abstract: The increasing number of invasive procedures done with contrast agents makes the prevention of their induced nephropathy more urgent. At present, different methods are being developed to prevent contrast-induced nephropathy (CIN) with antioxidants, intrarenal vasodilators, hydration therapy, by accurately determining the amount of excreted fluid obtained from a urinary catheter and less toxic iodine-containing contrast agents are being put into practice. Unfortunately, the current guidelines for the prevention of CIN are inadequately followed in both Russia and foreign countries. This review covers the main components of the pathogenesis and risk factors of this pathology and its possible preventive measures.
authors.forename: O Iu
authors.initials: OIu
authors.lastname: Mironova
mesh_terms: D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use; D003287:Contrast Media / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005440:Fluid Therapy; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000975:Antioxidants; D003287:Contrast Media; D014665:Vasodilator Agents